Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in the Western world, and it’s likely to parallel the increasing prevalence of type 2 diabetes, obesity, and other components of metabolic syndrome. However, optimal treatment for NAFLD has...

Descripción completa

Detalles Bibliográficos
Autores principales: Mengesha, Tewodros, Sekaran, N. Gnana, Mehare, Tsegaye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011178/
https://www.ncbi.nlm.nih.gov/pubmed/33785007
http://dx.doi.org/10.1186/s12906-021-03275-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011178/
https://www.ncbi.nlm.nih.gov/pubmed/33785007
http://dx.doi.org/10.1186/s12906-021-03275-5

Ejemplares similares